Teladoc Health Inc.
Organization details
- Legal name
- Teladoc Health Inc.
- Former names
- Teladoc, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 8011 — Services-Offices & Clinics of Doctors of Medicine
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- New York
- Headquarters state / province
- New York
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- TDOC
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0001477449
- EIN
- 04-3705970
- Wikidata ID
- Q20715093
Board of directors
-
Catherine Jacobson · DirectorSince 2023
-
Charles Divita III · Director · CHIEF EXECUTIVE OFFICERSince 2024
-
David B. Snow Jr. · DirectorSince 2023
-
David L. Shedlarz · DirectorSince 2023
-
Jason Eric Evans · DirectorSince 2023
-
Jason N. Gorevic · Director · CHIEF EXECUTIVE OFFICERSince 2023
-
Karen L. Daniel · DirectorSince 2023
-
Kenneth H. Paulus · DirectorSince 2023
-
Mark Anquillare V · DirectorSince 2026
-
Mark Douglas Smith · DirectorSince 2023
-
Michael S. Smith · DirectorSince 2026
-
Sandra L. Fenwick · DirectorSince 2023
-
Susan R. Salka · DirectorSince 2026
-
Thomas Mckinley · DirectorSince 2023
Chief executives
Weak · grade F
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 34
-1.4% a year in revenue
20% of the scoring weight is on file. Figures cover December 2023 – December 2025.
Director election results
Annual meeting of May 21, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
83.9%
-
92.0%
-
92.0%
-
93.0%
-
93.3%
-
94.0%
-
94.0%
-
94.2%
-
97.5%
Board connections
6 of this board's directors also sit on 8 other boards. 2 are in the same sector.
- via Karen L. Daniel
- via Mark Anquillare V
-
Jazz Pharmaceuticals plc Same sectorvia Mark Douglas Smith
- via Jason N. Gorevic
-
McKesson Corporation Same sectorvia Susan R. Salka
- via Mark Douglas Smith
- via David L. Shedlarz
- via Karen L. Daniel
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $2,656,373
- 38 sales by 6 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 6, 2026 | Nueno Carlos Officer (President, International) | Open-market sale | −29,432 | $9.20 | $270,774 |
| Oct 2, 2026 | Catapano Joseph Ronald Officer (Chief Accounting Officer) | Open-market sale | −655 | $5.65 | $3,703 |
| Oct 1, 2026 | Catapano Joseph Ronald Officer (Chief Accounting Officer) | Option exercise | +2,083 | — | — |
| Sep 11, 2026 | Charles Divita III Director, Officer (CHIEF EXECUTIVE OFFICER) | Open-market sale | −17,805 | $6.10 | $108,611 |
| Sep 10, 2026 | Charles Divita III Director, Officer (CHIEF EXECUTIVE OFFICER) | Option exercise | +3,642 | — | — |
| Sep 10, 2026 | Charles Divita III Director, Officer (CHIEF EXECUTIVE OFFICER) | Option exercise | +39,160 | — | — |
| Sep 3, 2026 | Rodrigues Fernando M. Officer (President of BetterHelp) | Open-market sale | −9,812 | $6.51 | $63,876 |
| Sep 2, 2026 | Catapano Joseph Ronald Officer (Chief Accounting Officer) | Open-market sale | −274 | $6.30 | $1,726 |
| Sep 2, 2026 | Charles Divita III Director, Officer (CHIEF EXECUTIVE OFFICER) | Open-market sale | −18,327 | $6.30 | $115,460 |
| Sep 2, 2026 | Nueno Carlos Officer (President, International) | Open-market sale | −6,200 | $6.30 | $39,060 |
| Sep 2, 2026 | Bliss Kelly Officer (President, U.S. Group Health) | Open-market sale | −7,357 | $6.30 | $46,349 |
| Sep 2, 2026 | Rodrigues Fernando M. Officer (President of BetterHelp) | Open-market sale | −5,439 | $6.30 | $34,266 |
| Sep 2, 2026 | Vandervoort Adam C Officer (CHIEF LEGAL OFFICER, SECRETARY) | Open-market sale | −7,573 | $6.30 | $47,710 |
| Sep 1, 2026 | Bliss Kelly Officer (President, U.S. Group Health) | Option exercise | +4,859 | — | — |
| Sep 1, 2026 | Catapano Joseph Ronald Officer (Chief Accounting Officer) | Option exercise | +833 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Teladoc Health Inc.
Who is the CEO of Teladoc Health Inc.?
Charles Divita III has been Teladoc Health Inc.'s CHIEF EXECUTIVE OFFICER since June 2024.
How many directors are on Teladoc Health Inc.'s board?
Teladoc Health Inc.'s board has 14 directors: Catherine Jacobson, Charles Divita III, David B. Snow Jr., David L. Shedlarz, Jason Eric Evans, Jason N. Gorevic, Karen L. Daniel, Kenneth H. Paulus, Mark Anquillare V, Mark Douglas Smith and 4 others.
Are Teladoc Health Inc. insiders buying or selling shares?
Over the last 12 months, Teladoc Health Inc. insiders made no open-market purchases and sold $2.7 million of shares in 38 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="teladoc-health-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.